NECAB2 | N-terminal EF-hand calcium binding protein 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
NPHS1 | Nephrosis 1, congenital, Finnish type (nephrin) | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NPR3 | Natriuretic peptide receptor 3 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
OGDHL | Oxoglutarate dehydrogenase-like | Citric acid cycle related proteins Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
OTOGL | Otogelin-like | Disease related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
OVCH2 | Ovochymase 2 (gene/pseudogene) | Predicted secreted proteins
| | | | | Tissue enhanced |
OXGR1 | Oxoglutarate (alpha-ketoglutarate) receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PALM3 | Paralemmin 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PAQR5 | Progestin and adipoQ receptor family member V | Predicted membrane proteins
| | | | | Tissue enhanced |
PARD6B | Par-6 family cell polarity regulator beta | Predicted intracellular proteins
| | | | | Tissue enhanced |
PCK1 | Phosphoenolpyruvate carboxykinase 1 (soluble) | Citric acid cycle related proteins Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
PCSK1N | Proprotein convertase subtilisin/kexin type 1 inhibitor | Predicted secreted proteins
| | | | | Tissue enhanced |
PDZD3 | PDZ domain containing 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PDZK1 | PDZ domain containing 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PKLR | Pyruvate kinase, liver and RBC | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
PNPLA3 | Patatin-like phospholipase domain containing 3 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
PRLR | Prolactin receptor | Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PTGER1 | Prostaglandin E receptor 1 (subtype EP1), 42kDa | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
RANBP3L | RAN binding protein 3-like | Predicted intracellular proteins
| | | | | Tissue enhanced |
RBP5 | Retinol binding protein 5, cellular | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
REN | Renin | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
RENBP | Renin binding protein | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
RNF183 | Ring finger protein 183 | Predicted membrane proteins
| | | | | Tissue enhanced |
RP11-162P23.2 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000450353} | Predicted intracellular proteins
| | | | | Tissue enhanced |
RP11-407N17.3 | CTAGE family member 5 {ECO:0000313|Ensembl:ENSP00000452252} | Predicted membrane proteins
| | | | | Tissue enhanced |
RP11-520P18.5 | Protein LOC101928108 {ECO:0000313|Ensembl:ENSP00000455811} | Predicted secreted proteins
| | | | | Tissue enhanced |
SCIN | Scinderin | Cytoskeleton related proteins Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SCNN1G | Sodium channel, non-voltage-gated 1, gamma subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SEMG2 | Semenogelin II | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SFXN2 | Sideroflexin 2 | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
SGK2 | Serum/glucocorticoid regulated kinase 2 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
SHISA3 | Shisa family member 3 | Predicted membrane proteins
| | | | | Tissue enhanced |
SIM2 | Single-minded family bHLH transcription factor 2 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
SLC13A1 | Solute carrier family 13 (sodium/sulfate symporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC14A2 | Solute carrier family 14 (urea transporter), member 2 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC16A4 | Solute carrier family 16, member 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
SLC16A9 | Solute carrier family 16, member 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC23A1 | Solute carrier family 23 (ascorbic acid transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC23A3 | Solute carrier family 23, member 3 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC25A48 | Solute carrier family 25, member 48 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC26A1 | Solute carrier family 26 (anion exchanger), member 1 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC2A9 | Solute carrier family 2 (facilitated glucose transporter), member 9 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC30A2 | Solute carrier family 30 (zinc transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC39A5 | Solute carrier family 39 (zinc transporter), member 5 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
SLC3A1 | Solute carrier family 3 (amino acid transporter heavy chain), member 1 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
SLC47A1 | Solute carrier family 47 (multidrug and toxin extrusion), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC4A4 | Solute carrier family 4 (sodium bicarbonate cotransporter), member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLCO4C1 | Solute carrier organic anion transporter family, member 4C1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SMCO3 | Single-pass membrane protein with coiled-coil domains 3 | Predicted membrane proteins
| | | | | Tissue enhanced |
SMIM24 | Small integral membrane protein 24 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |